Trending Market News

Boeing and its largest white-collar union, SPEEA, will resume contract negotiations on Monday after the union's 17,000 members overwhelmingly rejected Boeing's previous contract offer last week. Union members, including engineers and technical workers, are demanding larger and immediate guaranteed wage increases from the aerospace manufacturer.

• SPEEA represents approximately 17,000 Boeing engineers and technical workers who voted down the company's contract proposal
• Union survey results indicate members' top priority is larger, immediate guaranteed wage increases from Boeing
• Negotiations had stalled following last week's rejection, with Monday's meeting marking the resumption of contract discussions

Apple increased the price of its Apple TV+ streaming service to $14.99 per month (or $119 annually) from $12.99 per month, and raised Apple One bundle subscription pricing to $21.95 from $19.95 monthly. The price hikes bring Apple TV+ closer to rival streaming services after launching at $4.99 per month in 2019, reflecting significant content expansion including major productions like 'F1' and the return of 'Ted Lasso.'

• Apple TV+ monthly price increased 15% to $14.99 ($119/year), up from the original 2019 launch price of $4.99/month as content library has significantly expanded
• Apple One bundle subscription rose to $21.95 from $19.95, affecting customers who combine Apple TV+, iCloud storage, Apple Music and other services
• Apple's services segment generated $30.7 billion in revenue with 12% growth, though gross margin declined over 1% sequentially due to product mix and foreign exchange pressures

Russian gas producer Gazprom reported a 12% decline in first-half 2025 profit to 864 billion roubles ($10 billion), primarily due to a stronger rouble weighing on financial results. However, second-quarter net income surged over 60% year-on-year to 518.6 billion roubles, supported by higher oil and gas prices.

• Second-quarter profit jumped 60% to 518.6 billion roubles thanks to higher oil and gas prices, offsetting weak first-half performance
• A stronger rouble negatively impacted financial results since many sales are paid in international currencies, making rouble-reported earnings comparatively weaker
• Gazprom expects 6-7% growth in core earnings this year driven by increased domestic supplies and exports to China, as the company has lost most European customers since 2022

Walmart has reached a settlement with the U.S. Department of Justice over allegations that its pharmacies unlawfully dispensed opioid prescriptions, contributing to the nationwide opioid epidemic. The settlement resolves claims that Walmart's pharmacies failed to comply with obligations under the Controlled Substances Act.

• The lawsuit accused Walmart of fueling the opioid epidemic through improper dispensing practices at its pharmacy locations
• Financial terms of the settlement were not disclosed at the time of the announcement
• The DOJ alleged Walmart pharmacies violated the Controlled Substances Act in dispensing opioids and other controlled substances

Moderna and Merck achieved a breakthrough with their mRNA cancer vaccine, marking the first successful therapeutic cancer vaccine in late-stage testing after over a century of failed attempts. In a trial of more than 1,000 melanoma patients, the personalized vaccine prevented tumors from recurring or spreading when combined with Merck's Keytruda. U.S. approval could come as soon as next year, offering Moderna a lifeline amid declining COVID vaccine demand and Merck a valuable asset ahead of Keytruda's patent expiration.

• Merck paid $200 million upfront in 2016 and $250 million in 2022 for the partnership, with Wall Street already estimating billions in potential sales for the approved vaccine
• The vaccine (intismeran autogene) targets up to 34 patient-specific cancer mutations using mRNA technology, paired with Keytruda to unleash immune system T-cells against tumors
• The companies are testing whether the approach works in cancers with fewer mutations, including lung, kidney, and pancreatic cancers, while refining the current melanoma vaccine

Cytokinetics presented late-stage trial data showing its heart drug aficamten significantly improved symptoms in patients with non-obstructive hypertrophic cardiomyopathy (nHCM), a genetic heart condition with no approved treatments. The company plans to file for expanded U.S. approval in Q4 2026, with analysts forecasting over $5 billion in peak sales for the drug across both obstructive and non-obstructive forms of the condition.

• 53% of patients on aficamten showed meaningful improvements in at least three of five key disease areas compared to just 13% on placebo in the 517-patient study
• Safety concerns emerged as 10% of patients experienced dangerous drops in heart pumping capacity and 12 heart failure events occurred during the study, attributed to rigid trial dosing protocols
• Cytokinetics is expected to hold the nHCM market alone for multiple years before Bristol Myers begins late-stage trials of rival drug Camzyos later this year

Chinese food delivery giant Meituan reported a return to profitability in Q2 2026, posting adjusted net profit of 2.16 billion yuan after a quarterly loss, as intense price competition in China's instant delivery market eased following regulatory pressure. Revenue reached 104.6 billion yuan, up 14.4% year-over-year and beating analyst expectations.

• Meituan swung to 2.16 billion yuan adjusted net profit from a 4.97 billion yuan loss in Q1, driven by subsiding price wars that regulators criticized as a 'race to the bottom'
• Competition intensified after Alibaba's Taobao and JD.com launched instant retail platforms in early 2025, pressuring Meituan's margins for over a year before easing in 2026
• China's market regulator fined seven e-commerce platforms including Meituan a combined 3.6 billion yuan in April over food delivery safety violations

Lucid is recalling 27,185 of its flagship Air luxury sedans in the U.S. due to a fire risk from an exterior lighting circuit that could overheat. The NHTSA announced the recall on Friday, advising owners to park vehicles outside and away from structures until the issue is resolved.

• The recall affects over 27,000 Lucid Air sedans due to an overheating exterior lighting circuit that increases fire risk
• NHTSA has instructed owners to park their vehicles outside and away from structures as a precautionary measure until repairs are completed
• Lucid has released an over-the-air software update to address the safety issue

Google has modified its spam policy in Europe to avoid potential antitrust fines under the EU's Digital Markets Act. The change addresses complaints from publishers that Google's site reputation abuse policy was demoting news media and publisher websites in search results when they included content from commercial partners. Starting August 30, manual demotion actions will not apply to users in the European Economic Area.

• The policy targets 'parasite SEO' where third-party pages abuse search rankings through host site signals, but EU regulators found it was harming legitimate publisher content
• Google will exempt the 27 EU nations plus Iceland, Norway, and Liechtenstein from manual site demotions, while maintaining the policy unchanged elsewhere
• The European Commission had opened a Digital Markets Act investigation, which can impose fines up to 10% of global annual turnover for violations

BioXcel Therapeutics, an AI-driven biopharmaceutical company, filed for Chapter 11 bankruptcy protection in Delaware on August 27. The company reported estimated liabilities of $100-500 million against assets of only $10-50 million, highlighting severe financial distress despite recent creditor support.

• BioXcel secured an amended credit agreement on Monday providing an additional $1.25 million in loans from creditors just days before the bankruptcy filing
• The company's liabilities ($100-500 million) far exceed its assets ($10-50 million), indicating a significant balance sheet deficit
• BioXcel focuses on neurological medications, with its experimental drug BXCL501 marketed as an acute treatment for agitation associated with Alzheimer's dementia

A consortium consisting of buyout firm Advent International and payment processor Stripe has abandoned its pursuit of acquiring PayPal, according to Bloomberg News citing sources familiar with the matter. Reuters could not immediately verify the report. The decision ends what would have been a major fintech consolidation deal.

• The buyout consortium included Advent International (private equity firm) and Stripe (payment processor)
• The target was PayPal, described as a 'fintech pioneer' in the digital payments space
• Reuters has not independently verified Bloomberg's report about the abandoned acquisition pursuit

U.S. President Donald Trump escalated rhetoric against China by threatening sanctions on Chinese banks over Iran-related activities, even as officials from both countries met in Beijing to prepare for Chinese President Xi Jinping's planned state visit to Washington next month. Despite the tough rhetoric, both sides continue to focus on cooperation, signaling a balancing act between confrontation and diplomatic engagement.

• U.S. Treasury Secretary Scott Bessent warned Chinese banks could face sanctions if they participate in converting Iranian oil into money, though specific details remain limited and China's official response has been muted
• U.S. Ambassador David Perdue met with Chinese Foreign Minister Wang Yi and other officials in Beijing to prepare for Xi's upcoming Washington visit, with both sides confirming communication about the summit
• Analysts view the threats as largely performative, expecting the U.S.-China trade truce to remain intact as Beijing can comply with U.S. sanctions while maintaining its own legal framework for domestic operations

The U.S. Federal Trade Commission is investigating whether YouTube violated consumer protection laws by suspending user accounts and potentially misleading users about its content policies. The probe, which began last year, is in final stages and could result in a lawsuit against Alphabet's video-sharing platform, though some FTC career staff reportedly disagree with pursuing the case.

• The FTC is examining whether YouTube banned or demoted content in violation of its own user policies, potentially misleading users who signed up believing certain content was permitted
• The investigation is led by FTC Chairman Andrew Ferguson, who has signaled increased scrutiny of how online platforms enforce their speech policies
• Some career staff in the FTC's Bureau of Consumer Protection have privately expressed disagreement with filing the case, and investigations may end without enforcement action

BitGo has agreed to acquire NYDIG's institutional trading business to strengthen its position in crypto trading infrastructure. The deal will bring approximately 30 employees and 250 institutional client relationships to BitGo, expanding its services beyond custody into derivatives and capital markets. The acquisition comes amid growing mainstream adoption of cryptocurrencies under a crypto-friendly Trump administration.

• The acquisition adds about 30 NYDIG employees and 250 institutional client relationships to BitGo's operations
• BitGo will expand its service offerings to include derivatives, structured products, financing, and other capital markets services alongside its existing custody and wallet infrastructure
• BitGo went public earlier in 2025, raising approximately $213 million in its IPO, and is one of the largest crypto custody firms in the United States

The Trump administration is negotiating a deal with Venezuela to secure long-term U.S. access to a portion of Venezuela's oil reserves. The agreement would allow the U.S. government to designate specific Venezuelan oilfields for development by American companies, with the resulting oil supply guaranteed for the United States.

• The deal is being discussed at the highest levels of both governments and could be announced soon, with a 'lease' model under consideration as the legal framework
• Implementation would involve the U.S. locking in a group of Venezuelan oilfields, followed by auctions or tenders to allocate individual fields among American oil producers
• Neither the White House, U.S. Department of Energy, Venezuela's oil ministry, nor state oil company PDVSA provided immediate comment on the negotiations

The FDA approved Gilead's Bixlenvo, a once-daily HIV pill combining bictegravir and lenacapavir, designed to simplify treatment for patients whose virus is suppressed but who remain on complex multi-pill regimens. The drug targets an estimated 5% or more of HIV patients in the U.S. who cannot use existing single-tablet options due to drug resistance, side effects, or drug interactions. The approval is based on Phase 3 trials showing the pill maintained viral suppression at 48 weeks with minimal side effects.

• Bixlenvo is priced at $4,595 for a 30-day supply, in line with other daily single-tablet HIV treatments, with patient assistance programs available for uninsured and insured patients
• The drug combines bictegravir (from blockbuster Biktarvy) with lenacapavir, a first-in-class capsid inhibitor central to Gilead's long-term HIV strategy including daily pills and six-month injectables
• Phase 3 trials included patients with median age 60 taking 2-11 pills daily before switching, with most common side effects being headache, nausea and diarrhea in at least 2% of participants

The U.S. FDA has approved updated COVID-19 vaccines from Moderna, Novavax-Sanofi, and Pfizer-BioNTech for the 2026-27 season, targeting the dominant XFG variant. The approval follows an advisory panel's recommendation in May, where eight of nine experts voted in favor of targeting XFG. Four vaccine formulations were approved, including three mRNA-based shots and one protein-based vaccine.

• Four COVID vaccines approved: Moderna's mNEXSPIKE and Spikevax, Pfizer-BioNTech's Comirnaty (all mRNA-based), and Novavax-Sanofi's protein-based shot which requires longer manufacturing time
• The XFG variant target represents a shift from the 2025-26 season vaccines, which targeted the LP.8.1 subvariant of the JN.1 strain
• Current COVID strain data from the CDC is unavailable due to low sequencing submissions, though all manufacturers confirmed they can produce updated shots in time for the 2026-27 immunization season

Canada's ambassador to the U.S. stated that any trade deal must protect the Canadian auto assembly and parts industry, following the collapse of trade talks. President Trump imposed 50% tariffs on $20 billion in Canadian goods after negotiations failed, with Canada retaliating with $20 billion in tariffs set to take effect September 8.

• Trump's tariffs target Canadian wine, furniture, dairy, cement, clothing, fishing rods, and hockey equipment, bypassing protections under the existing three-nation trade deal with Mexico
• The breakdown centered on disagreements over tariff cuts for medium- and heavy-duty vehicles, with the U.S. Commerce Secretary claiming Canada raised the issue only in the final hours of talks
• Ambassador Wiseman emphasized Canada's 'resolve' and willingness to continue negotiations while preserving 'all options,' though no dates for resuming talks have been announced

Gap Inc. announced Michael Francis as the new CEO of Old Navy, effective November 2, replacing Haio Barbeito who held the position since 2022. The leadership change follows Old Navy's disappointing fiscal Q2 results, with comparable sales down 4% year-over-year, marking the brand's first negative same-store sales since Q2 2023. Old Navy contributes nearly 60% of Gap Inc.'s total revenue.

• Old Navy's Q2 net sales fell 4% to $2.1 billion, worse than the expected 2.4% decline, attributed to an 'unanticipated slowdown in traffic' and weak summer marketing that 'lacked a direct product message'
• Gap Inc. narrowed its full-year net sales growth outlook from 1-2% to 1-1.5% due to Old Navy's underperformance, though the company raised its adjusted EPS guidance
• Gap's namesake brand showed strong performance with comparable sales up 10% (beating 8.6% expectations), while Athleta struggled with a 12% decline in comparable sales

Ulta Beauty raised its annual sales and profit forecasts on August 27, citing strong beauty demand driven by marketing and product investments despite macroeconomic uncertainty. The cosmetics retailer increased its full-year sales growth outlook and comparable sales projections for fiscal 2026.

• Full-year sales growth forecast raised to 6.7%-7.2%, up from the prior range of 6%-7%
• Fiscal 2026 comparable sales now expected to grow 3.2%-3.7%, versus previous forecast of 2.5%-3.5%
• The upgrade reflects confidence that strategic investments in marketing and product assortment will sustain demand despite macroeconomic headwinds